- Home
- YMAB vs MERC Comparison
YMAB vs MERC Comparison
Compare YMAB & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- MERC
- Stock Information
- Founded
- YMAB 2015
- MERC 1968
- Country
- YMAB United States
- MERC Canada
- Employees
- YMAB N/A
- MERC N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- MERC Paper
- Sector
- YMAB Health Care
- MERC Basic Materials
- Exchange
- YMAB Nasdaq
- MERC Nasdaq
- Market Cap
- YMAB 482.4M
- MERC 428.0M
- IPO Year
- YMAB 2018
- MERC 1987
- Fundamental
- Price
- YMAB $9.38
- MERC $6.43
- Analyst Decision
- YMAB Strong Buy
- MERC Hold
- Analyst Count
- YMAB 10
- MERC 2
- Target Price
- YMAB $21.00
- MERC $7.75
- AVG Volume (30 Days)
- YMAB 243.1K
- MERC 286.8K
- Earning Date
- YMAB 11-08-2024
- MERC 02-13-2025
- Dividend Yield
- YMAB N/A
- MERC 4.64%
- EPS Growth
- YMAB N/A
- MERC N/A
- EPS
- YMAB N/A
- MERC N/A
- Revenue
- YMAB $84,553,000.00
- MERC $2,025,449,000.00
- Revenue This Year
- YMAB $6.46
- MERC $4.77
- Revenue Next Year
- YMAB $20.68
- MERC $1.72
- P/E Ratio
- YMAB N/A
- MERC N/A
- Revenue Growth
- YMAB N/A
- MERC N/A
- 52 Week Low
- YMAB $6.09
- MERC $5.33
- 52 Week High
- YMAB $20.90
- MERC $11.20
- Technical
- Relative Strength Index (RSI)
- YMAB 32.17
- MERC 49.45
- Support Level
- YMAB $9.31
- MERC $6.38
- Resistance Level
- YMAB $11.10
- MERC $6.82
- Average True Range (ATR)
- YMAB 0.72
- MERC 0.22
- MACD
- YMAB -0.00
- MERC 0.02
- Stochastic Oscillator
- YMAB 3.87
- MERC 51.70
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The solid wood segment consists of the manufacture, sale, and distribution of lumber, manufactured products wood pallets, electricity, biofuels, and wood residuals from sawmills and other facilities located in Germany and the United States. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.